Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H34N6O |
InChIKeyXNUNVQKARNSSEO-UHFFFAOYSA-N |
CAS Registry1373268-67-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 3 | ES | 01 Apr 2016 | |
Advanced Malignant Solid Neoplasm | Phase 3 | US | 01 Apr 2016 | |
Recurrent Glioblastoma | Phase 3 | US | 01 Apr 2016 | |
Recurrent Glioblastoma | Phase 3 | ES | 01 Apr 2016 | |
Glioblastoma | Phase 2 | - | - | |
Glioblastoma | Phase 2 | - | - |